Work

Redistribution of CD163+ CCR2+ Monocytes from Blood Circulation to the Ascites as a Potential Indicator of Progression in High-Grade Serous Ovarian Cancer

Year: 2026
Type: article
Study design: Observational Study
Abstract: This study aimed to identify tumor-specific changes in circulating and ascites-derived monocytes from high-grade serous ovarian carcinoma (HGSOC) patients using flow cytometry, immunohistochemistry, RNA sequencing, and in vitro experiments. Our results demonstrate that the tumor induces a decrease in the total number of circulating monocytes but an increase in the proportion of CD163+ monocytes. Notably, CD206-expressing monocytes were reduced in HGSOC patients, with extremely low CD206 levels in peripheral blood mirroring those in tumor tissues. In contrast, a marked accumulation of CD206-positive monocyte-derived macrophages was observed in malignant ascites. The presence of CCR2 on the monocyte surface further amplified the increase in CD163+ monocytes and reversed the decrease in CD206+ monocytes in cancer patients. Transcriptional levels of CD163 corresponded to protein levels and were elevated in monocytes of HGSOC patients. Moreover, the percentage of CD163+CCR2+ monocytes was decreased in peripheral blood but increased in ascites of patients with progressive disease. A functional migration assay confirmed extensive recruitment of monocytes toward malignant ascites in vitro. Collectively, our findings suggest that the redistribution of CD163+CCR2+ monocytes from blood to malignant ascites may represent a candidate indicator of disease progression in HGSOC patients.
Language: English
Subfield: Immunology
Open Access status: gold
Estimated APC paid: $3,499
OpenAlex ID: W7236843446
FWCI:
Cites:
Cited by:
Related to: 10